Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Evolutience Pharmaceutical AB
AB
In liquidation
Org 5592639511
Reproduction of recorded media
·
NACE 1820
Est. 2020 · 6 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Reproduction of recorded media
/
Evolutience Pharmaceutical AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
LO
Lars Olof Arne Alderling
Liquidator
Liquidator
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Former (6)
HJ
Hans Jarl Rutger Arnhult
Deputy Board Member
Deputy Board Member
2020 – 2022
BD
Bo Daniel Falk
Deputy Board Member
Deputy Board Member
2020 – 2022
AS
Agapi Sahakyan
Deputy Board Member
Deputy Board Member
2022 – 2022
LA
Lars Anders Larsson
Board of Directors
Board of Directors
2020 – 2022
KA
Karl Anders Blom
Board of Directors
Board of Directors
2022 – 2022
JB
Joulian Blagoy Aleksov
Chairman
Chairman
2022 – 2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Evolutience Pharmaceutical AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
Riskpilot